- Home
- CAC vs ORIC Comparison
CAC vs ORIC Comparison
Compare CAC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ORIC
- Stock Information
- Founded
- CAC 1875
- ORIC 2014
- Country
- CAC United States
- ORIC United States
- Employees
- CAC N/A
- ORIC N/A
- Industry
- CAC Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ORIC Health Care
- Exchange
- CAC Nasdaq
- ORIC Nasdaq
- Market Cap
- CAC 688.3M
- ORIC 974.1M
- IPO Year
- CAC 1997
- ORIC 2020
- Fundamental
- Price
- CAC $39.82
- ORIC $10.52
- Analyst Decision
- CAC Buy
- ORIC Strong Buy
- Analyst Count
- CAC 3
- ORIC 10
- Target Price
- CAC $48.00
- ORIC $17.33
- AVG Volume (30 Days)
- CAC 56.5K
- ORIC 903.1K
- Earning Date
- CAC 10-28-2025
- ORIC 11-11-2025
- Dividend Yield
- CAC 4.22%
- ORIC N/A
- EPS Growth
- CAC 4.80
- ORIC N/A
- EPS
- CAC 3.11
- ORIC N/A
- Revenue
- CAC $197,501,000.00
- ORIC N/A
- Revenue This Year
- CAC $42.11
- ORIC N/A
- Revenue Next Year
- CAC $5.51
- ORIC N/A
- P/E Ratio
- CAC $12.78
- ORIC N/A
- Revenue Growth
- CAC 21.74
- ORIC N/A
- 52 Week Low
- CAC $34.53
- ORIC $3.90
- 52 Week High
- CAC $50.07
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- CAC 47.61
- ORIC 51.83
- Support Level
- CAC $39.82
- ORIC $10.37
- Resistance Level
- CAC $40.75
- ORIC $11.16
- Average True Range (ATR)
- CAC 0.84
- ORIC 0.53
- MACD
- CAC -0.08
- ORIC 0.03
- Stochastic Oscillator
- CAC 16.49
- ORIC 46.43
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.